ArticleCancer cell international2019

Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.

Li-Juan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.